Sichuan Kelun Pharmaceutical synthesizes CYP51 inhibitors
AI Briefing
- Sichuan Kelun Pharmaceutical discovers CYP51 inhibitors for Candidal and aspergillosis treatment
- CYP51 inhibitors may help combat fungal infections
- New compound may be used to treat fungal infections
Advertisement